Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease

Farah Sheikh, Kunfu Ouyang, Stuart G. Campbell, Robert C. Lyon, Joyce Chuang, Dan Fitzsimons, Jared Tangney, Carlos G. Hidalgo, Charles S. Chung, Hongqiang Cheng, Nancy D. Dalton, Yusu Gu, Hideko Kasahara, Majid Ghassemian, Jeffrey H. Omens, Kirk L. Peterson, Hendrikus "Henk" Granzier, Richard L. Moss, Andrew D. McCulloch, Ju Chen

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Actin-myosin interactions provide the driving force underlying each heartbeat. The current view is that actinbound regulatory proteins play a dominant role in the activation of calcium-dependent cardiac muscle contraction. In contrast, the relevance and nature of regulation by myosin regulatory proteins (for example, myosin light chain-2 [MLC2]) in cardiac muscle remain poorly understood. By integrating gene-targeted mouse and computational models, we have identified an indispensable role for ventricular Mlc2 (Mlc2v) phosphorylation in regulating cardiac muscle contraction. Cardiac myosin cycling kinetics, which directly control actin-myosin interactions, were directly affected, but surprisingly, Mlc2v phosphorylation also fed back to cooperatively influence calcium-dependent activation of the thin filament. Loss of these mechanisms produced early defects in the rate of cardiac muscle twitch relaxation and ventricular torsion. Strikingly, these defects preceded the left ventricular dysfunction of heart disease and failure in a mouse model with nonphosphorylatable Mlc2v. Thus, there is a direct and early role for Mlc2 phosphorylation in regulating actin-myosin interactions in striated muscle contraction, and dephosphorylation of Mlc2 or loss of these mechanisms can play a critical role in heart failure.

Original languageEnglish (US)
Pages (from-to)1209-1221
Number of pages13
JournalJournal of Clinical Investigation
Volume122
Issue number4
DOIs
StatePublished - Apr 2 2012

Fingerprint

Myosins
Heart Diseases
Myocardium
Muscle Contraction
Actins
Phosphorylation
Heart Failure
Cardiac Myosins
Calcium
Muscle Relaxation
Striated Muscle
Left Ventricular Dysfunction
Genes
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sheikh, F., Ouyang, K., Campbell, S. G., Lyon, R. C., Chuang, J., Fitzsimons, D., ... Chen, J. (2012). Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease. Journal of Clinical Investigation, 122(4), 1209-1221. https://doi.org/10.1172/JCI61134

Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease. / Sheikh, Farah; Ouyang, Kunfu; Campbell, Stuart G.; Lyon, Robert C.; Chuang, Joyce; Fitzsimons, Dan; Tangney, Jared; Hidalgo, Carlos G.; Chung, Charles S.; Cheng, Hongqiang; Dalton, Nancy D.; Gu, Yusu; Kasahara, Hideko; Ghassemian, Majid; Omens, Jeffrey H.; Peterson, Kirk L.; Granzier, Hendrikus "Henk"; Moss, Richard L.; McCulloch, Andrew D.; Chen, Ju.

In: Journal of Clinical Investigation, Vol. 122, No. 4, 02.04.2012, p. 1209-1221.

Research output: Contribution to journalArticle

Sheikh, F, Ouyang, K, Campbell, SG, Lyon, RC, Chuang, J, Fitzsimons, D, Tangney, J, Hidalgo, CG, Chung, CS, Cheng, H, Dalton, ND, Gu, Y, Kasahara, H, Ghassemian, M, Omens, JH, Peterson, KL, Granzier, HH, Moss, RL, McCulloch, AD & Chen, J 2012, 'Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease', Journal of Clinical Investigation, vol. 122, no. 4, pp. 1209-1221. https://doi.org/10.1172/JCI61134
Sheikh, Farah ; Ouyang, Kunfu ; Campbell, Stuart G. ; Lyon, Robert C. ; Chuang, Joyce ; Fitzsimons, Dan ; Tangney, Jared ; Hidalgo, Carlos G. ; Chung, Charles S. ; Cheng, Hongqiang ; Dalton, Nancy D. ; Gu, Yusu ; Kasahara, Hideko ; Ghassemian, Majid ; Omens, Jeffrey H. ; Peterson, Kirk L. ; Granzier, Hendrikus "Henk" ; Moss, Richard L. ; McCulloch, Andrew D. ; Chen, Ju. / Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease. In: Journal of Clinical Investigation. 2012 ; Vol. 122, No. 4. pp. 1209-1221.
@article{a637076a98674c429e653a8d41f7235e,
title = "Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease",
abstract = "Actin-myosin interactions provide the driving force underlying each heartbeat. The current view is that actinbound regulatory proteins play a dominant role in the activation of calcium-dependent cardiac muscle contraction. In contrast, the relevance and nature of regulation by myosin regulatory proteins (for example, myosin light chain-2 [MLC2]) in cardiac muscle remain poorly understood. By integrating gene-targeted mouse and computational models, we have identified an indispensable role for ventricular Mlc2 (Mlc2v) phosphorylation in regulating cardiac muscle contraction. Cardiac myosin cycling kinetics, which directly control actin-myosin interactions, were directly affected, but surprisingly, Mlc2v phosphorylation also fed back to cooperatively influence calcium-dependent activation of the thin filament. Loss of these mechanisms produced early defects in the rate of cardiac muscle twitch relaxation and ventricular torsion. Strikingly, these defects preceded the left ventricular dysfunction of heart disease and failure in a mouse model with nonphosphorylatable Mlc2v. Thus, there is a direct and early role for Mlc2 phosphorylation in regulating actin-myosin interactions in striated muscle contraction, and dephosphorylation of Mlc2 or loss of these mechanisms can play a critical role in heart failure.",
author = "Farah Sheikh and Kunfu Ouyang and Campbell, {Stuart G.} and Lyon, {Robert C.} and Joyce Chuang and Dan Fitzsimons and Jared Tangney and Hidalgo, {Carlos G.} and Chung, {Charles S.} and Hongqiang Cheng and Dalton, {Nancy D.} and Yusu Gu and Hideko Kasahara and Majid Ghassemian and Omens, {Jeffrey H.} and Peterson, {Kirk L.} and Granzier, {Hendrikus {"}Henk{"}} and Moss, {Richard L.} and McCulloch, {Andrew D.} and Ju Chen",
year = "2012",
month = "4",
day = "2",
doi = "10.1172/JCI61134",
language = "English (US)",
volume = "122",
pages = "1209--1221",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease

AU - Sheikh, Farah

AU - Ouyang, Kunfu

AU - Campbell, Stuart G.

AU - Lyon, Robert C.

AU - Chuang, Joyce

AU - Fitzsimons, Dan

AU - Tangney, Jared

AU - Hidalgo, Carlos G.

AU - Chung, Charles S.

AU - Cheng, Hongqiang

AU - Dalton, Nancy D.

AU - Gu, Yusu

AU - Kasahara, Hideko

AU - Ghassemian, Majid

AU - Omens, Jeffrey H.

AU - Peterson, Kirk L.

AU - Granzier, Hendrikus "Henk"

AU - Moss, Richard L.

AU - McCulloch, Andrew D.

AU - Chen, Ju

PY - 2012/4/2

Y1 - 2012/4/2

N2 - Actin-myosin interactions provide the driving force underlying each heartbeat. The current view is that actinbound regulatory proteins play a dominant role in the activation of calcium-dependent cardiac muscle contraction. In contrast, the relevance and nature of regulation by myosin regulatory proteins (for example, myosin light chain-2 [MLC2]) in cardiac muscle remain poorly understood. By integrating gene-targeted mouse and computational models, we have identified an indispensable role for ventricular Mlc2 (Mlc2v) phosphorylation in regulating cardiac muscle contraction. Cardiac myosin cycling kinetics, which directly control actin-myosin interactions, were directly affected, but surprisingly, Mlc2v phosphorylation also fed back to cooperatively influence calcium-dependent activation of the thin filament. Loss of these mechanisms produced early defects in the rate of cardiac muscle twitch relaxation and ventricular torsion. Strikingly, these defects preceded the left ventricular dysfunction of heart disease and failure in a mouse model with nonphosphorylatable Mlc2v. Thus, there is a direct and early role for Mlc2 phosphorylation in regulating actin-myosin interactions in striated muscle contraction, and dephosphorylation of Mlc2 or loss of these mechanisms can play a critical role in heart failure.

AB - Actin-myosin interactions provide the driving force underlying each heartbeat. The current view is that actinbound regulatory proteins play a dominant role in the activation of calcium-dependent cardiac muscle contraction. In contrast, the relevance and nature of regulation by myosin regulatory proteins (for example, myosin light chain-2 [MLC2]) in cardiac muscle remain poorly understood. By integrating gene-targeted mouse and computational models, we have identified an indispensable role for ventricular Mlc2 (Mlc2v) phosphorylation in regulating cardiac muscle contraction. Cardiac myosin cycling kinetics, which directly control actin-myosin interactions, were directly affected, but surprisingly, Mlc2v phosphorylation also fed back to cooperatively influence calcium-dependent activation of the thin filament. Loss of these mechanisms produced early defects in the rate of cardiac muscle twitch relaxation and ventricular torsion. Strikingly, these defects preceded the left ventricular dysfunction of heart disease and failure in a mouse model with nonphosphorylatable Mlc2v. Thus, there is a direct and early role for Mlc2 phosphorylation in regulating actin-myosin interactions in striated muscle contraction, and dephosphorylation of Mlc2 or loss of these mechanisms can play a critical role in heart failure.

UR - http://www.scopus.com/inward/record.url?scp=84859715525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859715525&partnerID=8YFLogxK

U2 - 10.1172/JCI61134

DO - 10.1172/JCI61134

M3 - Article

C2 - 22426213

AN - SCOPUS:84859715525

VL - 122

SP - 1209

EP - 1221

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -